STOCK TITAN

IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IGM Biosciences, a clinical-stage biotechnology company, announced that CEO Fred Schwarzer will present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 11:40 a.m. ET. The presentation will focus on the company's development of engineered IgM antibodies. A live webcast will be accessible on the company's website, with an archived replay available for 90 days. IGM Biosciences has developed a proprietary IgM technology platform, aimed at overcoming challenges in the therapeutic application of IgM antibodies since its inception in 2010.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 11:40 a.m. ET.

A live webcast of the presentation will be available on the “Events and Presentations” page on the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com


FAQ

When will IGM Biosciences present at the J.P. Morgan Healthcare Conference?

IGM Biosciences will present on January 14, 2021, at 11:40 a.m. ET.

Where can I watch the IGM Biosciences presentation?

The presentation can be viewed live on the 'Events and Presentations' page on IGM Biosciences' website.

How long will the IGM Biosciences webcast be available for replay?

The replay of the webcast will be available for 90 days following the presentation.

What is the focus of IGM Biosciences' presentation?

The presentation will focus on the development of engineered IgM antibodies.

What technology platform does IGM Biosciences use?

IGM Biosciences has developed a proprietary IgM technology platform for antibody development.

IGM Biosciences, Inc.

NASDAQ:IGMS

IGMS Rankings

IGMS Latest News

IGMS Stock Data

565.21M
21.80M
35.05%
63.99%
5.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MOUNTAIN VIEW